Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Drug Delivery by Genetically Modified <i>Lactococcus lactis</i>

1 Aug 2006

Abstract excerpt

Food-grade bacteria have been consumed throughout history without associated pathologies and are, therefore, absolutely safe to ingest. Unexpectedly, Lactococcus lactis (L. lactis), known from cheese production, can be genetically engineered to constantly secrete satisfactory amounts of bioactive cytokines. Both of these features enabled the development of a new kind of topical delivery system: topical and active...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Probiotics and Fermented Foods
Share to Transgenic Plants and Applications
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17057198
DOI: 10.1196/annals.1326.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Drug Delivery by Genetically Modified <i>Lactococcus lactis</i>PMID 17057198Read ↗

Genetically modified Lactococcus lactis: novel tools for drug deliverySemantic proximity Read ↗

<i>Lactococcus lactis</i>as a live vector for mucosal delivery of therapeutic proteinsSemantic proximity Read ↗

Lactococcus lactis as a Cell Factory for Delivery of Therapeutic ProteinsSemantic proximity Read ↗

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10Semantic proximity Read ↗

Genetically engineered bacteria as inflammatory bowel disease therapeuticsSemantic proximity Read ↗

Construction of thyA deficient Lactococcus lactis using the Cre-loxP recombination systemSemantic proximity Read ↗

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an updateSemantic proximity Read ↗

Biocontainment strategies for <i>in vivo</i> applications of <i>Saccharomyces boulardii</i>Semantic proximity Read ↗

Effects in the use of a genetically engineered strain of<i>Lactococcus lactis</i>delivering in situ IL-10 as a therapy to treat low-grade colon inflammationSemantic proximity Read ↗

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccinesSemantic proximity Read ↗

Characterization of Nano-decorated L. Lactis as a putative Theranostic AgentSemantic proximity Read ↗

<i>Bacillus subtilis</i> engineered for aerospace medicine: a platform for off-planet production of pharmaceutical peptidesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.